Hepatitis C virus: Management of recurrent disease.
作者信息
Verna Elizabeth C
机构信息
Center for Liver Disease and Transplantation, Division of Digestive and Liver Diseases, Columbia University College of Physicians and Surgeons, New York, NY.
出版信息
Clin Liver Dis (Hoboken). 2013 Aug 19;2(4):177-180. doi: 10.1002/cld.220. eCollection 2013 Aug.
Abstract
摘要
相似文献
1
Hepatitis C virus: Management of recurrent disease.
Clin Liver Dis (Hoboken). 2013 Aug 19;2(4):177-180. doi: 10.1002/cld.220. eCollection 2013 Aug.
2
Controversies in the management of hepatitis C virus infection after liver transplantation.
Liver Transpl. 2003 Nov;9(11):1129-44. doi: 10.1053/jlts.2003.50261.
3
Management of liver transplant recipients with recurrent hepatitis C.
Curr Opin Organ Transplant. 2009 Jun;14(3):221-4. doi: 10.1097/MOT.0b013e32832ade76.
4
[Treatment of recurrent hepatitis C virus infection after liver transplantation].
Orv Hetil. 2007 Oct 7;148(40):1875-81. doi: 10.1556/OH.2007.28217.
5
Management of recurrent hepatitis C after liver transplantation: a concise review.
Am J Gastroenterol. 2000 Sep;95(9):2164-70. doi: 10.1111/j.1572-0241.2000.02296.x.
6
[Detection of hepatitis C virus RNA in tear film of a patient with recurrent peripheral corneal ulcers].
Klin Monbl Augenheilkd. 2001 Jun;218(6):459-62. doi: 10.1055/s-2001-16263.
7
Treatment of recurrent hepatitis C following liver transplantation.
Curr Gastroenterol Rep. 1999 Feb-Mar;1(1):15-9. doi: 10.1007/s11894-999-0081-8.
8
Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation.
Liver Transpl. 2000 Jul;6(4):407-12. doi: 10.1053/jlts.2000.7581.
9
IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
J Med Virol. 1998 Nov;56(3):224-9.
10
Management of recurrent hepatitis C in orthotopic liver transplant recipients.
Infect Dis Clin North Am. 2013 Jun;27(2):285-304. doi: 10.1016/j.idc.2013.02.003. Epub 2013 Apr 3.
本文引用的文献
1
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.
Lancet. 2013 Jun 15;381(9883):2100-7. doi: 10.1016/S0140-6736(13)60247-0. Epub 2013 Mar 15.
2
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.
N Engl J Med. 2013 Jan 3;368(1):34-44. doi: 10.1056/NEJMoa1208953.
3
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation.
J Gastroenterol. 2013 Jun;48(6):762-9. doi: 10.1007/s00535-012-0680-2. Epub 2012 Sep 26.
4
Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Liver Transpl. 2012 Sep;18(9):1029-36. doi: 10.1002/lt.23479.
5
Comparison of two non-contemporaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy.
J Hepatol. 2012 Jun;56(6):1310-6. doi: 10.1016/j.jhep.2011.12.031. Epub 2012 Feb 5.
6
Hepatitis C virus viral kinetics during α-2a or α-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes.
J Clin Virol. 2012 Mar;53(3):231-8. doi: 10.1016/j.jcv.2011.12.005. Epub 2012 Jan 4.
7
Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis.
Liver Transpl. 2012 Mar;18(3):323-31. doi: 10.1002/lt.22460.
8
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.
Am J Transplant. 2011 Nov;11(11):2379-87. doi: 10.1111/j.1600-6143.2011.03767.x. Epub 2011 Oct 3.
9
Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
Hepatology. 2011 Jul;54(1):20-7. doi: 10.1002/hep.24443.
10
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database.
Am J Transplant. 2011 Aug;11(8):1676-85. doi: 10.1111/j.1600-6143.2011.03508.x. Epub 2011 May 12.
Zotero 插件